AI health coach aims to tame diabetes in indonesia
NCT ID NCT07165730
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a 12-week virtual health coaching program powered by artificial intelligence can improve blood sugar control in adults with type 2 diabetes. 206 participants in Indonesia will be randomly assigned to use the DIACOACH app or receive standard diabetes education. The app provides personalized tips, reminders, and feedback on diet, exercise, and medication. Researchers will measure changes in fasting blood sugar and HbA1c levels.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Virtual health coaching via the DIACOACH app, which uses artificial intelligence to provide personalized diet, exercise, and medication reminders.
What this could lead to
If it works, this could offer a low-cost, scalable digital tool to help people with type 2 diabetes manage their blood sugar better, especially in communities with limited healthcare resources.
What could go wrong
This is a relatively small trial in two regions of Indonesia, so results may not apply to other populations. The intervention is behavioral, so improvements may be modest or hard to sustain long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Public Health Center of Bontomatene and Public Health Center of Binamu Kota
Makassar, South Sulawesi, 90245, Indonesia
Contact Phone: •••-•••-•••• Email: •••••@•••••